about
Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.Collapsing focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus.Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimenHelical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issuesAnti-DNA antibodies cross-react with C1qAn Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy.Post-chikungunya rheumatic disorders in travelers after return from the Caribbean.The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy.Fiber intake and risk of nasopharyngeal carcinoma: a case-control study.Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and head and neck cancers risk.Low-dose radiotherapy in diffuse large B-cell lymphoma.Malignant struma ovarii harboring a unique NRAS mutation: case report and review of the literature.Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models.Etanercept-induced myositis: do we have to stop it? A surprising outcome.Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopesIntensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experienceEffectiveness of selective neck dissection in head and neck cancer: the experience of two Italian centersStereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancerDirect health-care cost of head and neck cancers: a population-based study in north-eastern ItalyThe German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant
P50
Q33404379-05EE360E-E654-4A14-A523-7B4DD0D5B837Q33742722-0220A8A2-297D-4ACF-B4E2-F7ABE71279A6Q34087122-C33610E1-6FCC-4199-9275-885DAAE80A13Q34493493-D74C3428-53CE-4C6D-A56B-EF04DE4B93B8Q37148163-8DC28A46-2083-4433-9068-C484CDDC170EQ37411836-DD3A37B1-F9B4-4E78-96F3-9A4C1504FFC4Q38760196-794693CC-B8C6-43E0-97E1-9020B04E51EDQ38783775-E52232A0-0080-4CF1-BF9C-19F4218FDA29Q39538000-0158A213-2E30-4731-8273-95C79923D0FDQ40118411-4232D640-3C18-480D-BD0E-BAA74FB34C6DQ40269766-436C8326-DADD-4C99-B1ED-AD5B431FE8A5Q40634934-A467AC3F-D56A-49D7-A063-4D5D839E7FEFQ41157591-0750ECB8-3657-4A7B-958C-24C0108F66FCQ43535331-40BA6E4F-4947-4A01-9095-520F318AEC37Q44472236-4D99267D-BA8A-43B4-90ED-844828C38F9BQ44601385-A6E8451F-A02E-4649-870F-376F1EAF7E9AQ47598431-3C33C065-9C11-4B86-B7E9-5BA182F22C02Q47634173-08FB293F-2097-4613-AED4-2B28D3690463Q49573392-E484B9F9-56CF-4F2D-A7E9-BDAE14A265FDQ50934663-8384A7E3-EEA1-4636-B5BC-1973A29F350EQ54541002-E5FFCA98-4ED0-4A28-AE79-566851CE0A6DQ57056118-90116D36-DF98-489C-9EBF-1020AD950B44Q84587775-55829D04-DE8C-4219-B863-32CF22E3990CQ87148708-4A9C2EB2-95B2-446C-AF9F-A4E01DD549ABQ87505196-FCDDC273-AA12-479F-9F30-05BFD512D2DBQ91993252-032B3E67-64ED-4D45-B6C1-A126BABBD633Q92614963-B8E77197-3E32-46FB-B936-115B7B548460
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Giovanni Franchin
@en
Giovanni Franchin
@nl
type
label
Giovanni Franchin
@en
Giovanni Franchin
@nl
prefLabel
Giovanni Franchin
@en
Giovanni Franchin
@nl
P31
P496
0000-0003-1988-2739